Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.
Jens WiebeFelix J HofmannOliver DörrTimm BauerNiklas F BoederChristoph LiebetrauFlorian BlachutzikHelge MöllmannAlbrecht ElsässerStephan AchenbachChristian W HammHolger M NefPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Although this real-world registry displays high rates of clinical events during long-term follow-up, no ScT was seen after 2 years.